ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases

Breast cancer can recur even decades after the primary therapy. Markers are needed to predict cancer progression and the risk of late recurrence. The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), proliferation marker Ki-67, and cytokeratin CK5 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Joensuu, Kristiina, Leidenius, Marjut, Kero, Mia, Andersson, Leif C., Horwitz, Kathryn B., Heikkilä, Päivi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579427/
https://www.ncbi.nlm.nih.gov/pubmed/23514931
http://dx.doi.org/10.4137/BCBCR.S10701